
Kurma Partners
About
Kurma Partners is a European venture capital firm specializing in investments in innovative life sciences and healthcare companies. They focus on early-stage and growth-stage ventures in areas such as therapeutics, diagnostics, and digital health, primarily across Europe. Kurma aims to support entrepreneurs in transforming scientific breakthroughs into successful businesses that address unmet medical needs and improve patient outcomes.
Key facts
At-a-glance profile data
- Website
- kurmapartners.com
- Type
- Venture Capital
- Headquarters
- Paris, France
- Stages
- Growth EquityPre-SeedSeedSeries ASeries B
- Cheque size
- $14M to $96M
- Sector focus
- Life SciencesHealthcareBiotechnologyDigital HealthDiagnostics
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 8 Oct 2025 | Phagos | Series A | $27M |
| 29 Jan 2020 | SafeHeal | Undisclosed round | $17M |
Add first review
1 positive0 mixed0 negative
Frequently asked
What companies has Kurma Partners invested in?
Kurma Partners has invested in Phagos, SafeHeal.